Krystal Biotech, Inc. KRYS Non-Cash Lease Expense
Non-Cash Lease Expense at other companies
Other financials
Where this comes from
Reported directly by Krystal Biotech, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense.
The official record: Krystal Biotech, Inc.’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →
Ask your AI about Krystal Biotech, Inc.'s non-cash lease expense.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Krystal Biotech, Inc.'s non-cash lease expense?
- Krystal Biotech, Inc. (KRYS) reported non-cash lease expense of $204K in Q1 2026.
- How has Krystal Biotech, Inc.'s non-cash lease expense changed year-over-year?
- Krystal Biotech, Inc.'s non-cash lease expense decreased by 8.9% year-over-year, from $224K to $204K.
- What is the long-term trend for Krystal Biotech, Inc.'s non-cash lease expense?
- Over 3 years (2022 to 2025), Krystal Biotech, Inc.'s non-cash lease expense has grown at a 3.7% compound annual growth rate (CAGR), from $742K to $827K.
- What does non-cash lease expense mean?
- The non-cash portion of lease costs related to the usage of leased assets.
- How do you interpret non-cash lease expense?
- Changes reflect the scale of the company's physical footprint and lease commitments.
- How does non-cash lease expense compare across companies?
- Standard for any company with significant real estate or equipment lease obligations.